David Willetts has announced that the Technology Strategy Board is to create a new ‘Innovation Platform’ in Stratified Medicine.
This will bring business, government, academia and the research community together in a major initiative that will place the UK at the centre of a revolution in the diagnosis and treatment of disease.
The new programme will oversee an investment of over £50 million of government funding over 5 years in innovative research and development. This will include areas such as tumour profiling to improve cancer care and developing biomarkers for more effective drugs. The first funding competitions under this programme, worth up to £11 million, were also launched at the Innovate10 event, held on October 12.